Showing posts with label NANO. Show all posts
Showing posts with label NANO. Show all posts

Tuesday, February 27, 2024

Nanofilm Technologies FY2023 Earning Result

Nanofilm Technologies International Ltd ("Nanofilm") reported their FY2023 earning result this morning [here].  Here is a quick dive into the numbers:

Numbers in S$ million unless stated otherwise.
Twelve Months Ending 31 Dec 2023 31 Dec 2022 % Change
Revenue 177.02 237.41 (25.4)
Profit Before Tax 3.14 46.12 (93.2)
Net Profit 2.70 43.29 (93.8)
EPS (in cents) 0.48 6.65 (92.9)
DPS (in cents) 0.66 2.20 (70.0)

Nanofilm derives its revenue from its four business units: (a) Advanced Materials ("AM"), which involves their proprietary vacuum coating technology; (b) Nanofabrication ("NF"), which manufactures nanoproducts in optical imaging lens and sensory components; Industrial Equipment ("IE"), which develops customized coating equipment for customers; and (d) Sydrogen ("SD"), which provides fuel cell components and solutions.

Revenue broadly declined 25.4% y/y, attributed by lower sales achieved by the AM, IE and NF businesses.  This was partially offset by higher revenue from the SD business, primarily due to production ramp-up from new projects.  FY2023 EBITDA margin was 23.1% for AM (FY22: 36.4%), 33.0% for IE (FY22: 24.7%), 16.7% for NF (FY22: 32.9%).  SD operated at a loss of S$2.0M (FY22: -$1.6M).  Gross profit declined 41.1% y/y, primarily due to increase in material costs and increase in depreciation & amortizaton expenses.  Management does not expect significant capex in FY2024, but will focus on maximising returns from current asset base.  Management is confident of higher revenue and profit in FY2024, contingent upon absence of major unexpected events.

My Thoughts
Nanofilm derives the bulk of its revenue from its China operations (72.9%).  Singapore is second (20.2%).  The remaining comes from Japan and Vietnam.  2023 was a challenging year for manufacturers in China.  Despite the higher costs, EBITA margin had managed to maintain in double digits.  A lower final dividend payout was expected.  Hope 2024 will be better.  I had built up a sizeable position in Nanofilm as the market sold down the stock in 2023.  Will refrain from adding and monitor the company's performance going forward.




Enjoyed this post? Never miss out new posts by subscribing here.

Thursday, February 1, 2024

Portfolio Summary for January 2024

As of 31 January 2024

CDP

Security # shares Price S$ %
DBS 400 31.88 3.95
UOB 400 28.37 3.51
OCBC Bank 700 12.89 2.79
SGX 2,700 9.41 7.86
ST Engineering 6,900 3.73 7.96
Powermatic Data 8,500 3.00 7.89
Micro-Mechanics 14,200 1.75 7.69
Sheng Siong 19,100 1.56 9.22
TheHourGlass 19,600 1.53 9.28
VICOM Ltd 21,500 1.44 9.58
Credit Bureau Asia 14,300 0.89 3.94
Nanofilm 36,100 0.69 7.71
HRnetGroup 21,900 0.71 4.81
China Sunsine 41,800 0.395 5.11
TalkMed Group 14,500 0.375 1.68
Kimly 27,000 0.31 2.59
HC Surgical 35,500 0.295 3.24
Silverlake Axis 15,000 0.26 1.21
Portfolio Market Value = $323,237
YTD Dividends Received = $0
YTD SBL Fees Received = $3

Trades
- Bought 4,600 shares of TheHourGlass.
- Bought 14,500 shares of Nanofilm Technologies.

SRS

Security # shares Price S$ %
DBS 100 31.88 2.72
UOB 200 28.37 4.85
OCBC Bank 900 12.89 9.91
SGX 1,300 9.41 10.45
ST Engineering 3,000 3.73 9.56
Micro-Mechanics 5,400 1.75 8.07
Sheng Siong 8,700 1.56 11.59
TheHourGlass 5,000 1.53 6.54
VICOM Ltd 5,500 1.44 6.77
Credit Bureau Asia 5,700 0.89 4.33
Nanofilm 12,500 0.69 7.37
HRnetGroup 7,500 0.71 4.55
China Sunsine 10,800 0.395 3.64
TalkMed Group 5,800 0.375 1.86
Kimly 5,800 0.31 1.54
HC Surgical 19,500 0.295 4.91
Silverlake Axis 6,000 0.26 1.33
Portfolio Market Value = $117,053

Trades
- Bought 7,000 shares of Nanofilm Technologies.
- Sold 3,400 shares of Powermatic Data.

Singapore Savings Bonds

Security Amount ($) Avg Yld %
GX22120S 14,000 3.47
GX23010Z 15,000 3.26
GX23110V 20,000 3.32
GX23120Z 20,000 3.40
Portfolio Market Value = $69,000

Commentary:
The U.S. equity market started the year with a bang.  The S&500 Index hit a new lifetime high, despite investors realizing that the U.S. Fed may not cut interest rate so early in the year.


On the other hand, the local STI tripped and fell right out of the gate, losing 2.7% in January.  Major contributors to the loss include DFI Retail Group (-16.7%), Seatrium (-15.3%) and Jardine Cycle & Carriage (-12.6%).

I took the opportunity to load up on TheHourGlass and Nanofilm Technologies as the two counters faced heavy bouts of selling in the market.  So far I see no change to their underlying fundamentals, so I'm not worried.  (I cannot imagine a time when luxury watches go out of fashion.)

In the spirit of audacious New Year resolutions, I have set myself a goal to DOUBLE UP on my CDP portfolio investment in 2024.  It is a stretch target beyond common sense, but one I hope will spur me to catch up on my retirement plan.  I shall review the outcome in December!

Lately, I've also begun to think about the strategic direction I want to take with my SRS portfolio.  All along, I've built my SRS portfolio like a miniature version of my CDP portfolio, with my own weighting methodology and choice of stocks.  The benefit is that I have only one set of companies to monitor.

But it is starting to make no sense to me.  Firstly, the quantum of my SRS portfolio is small.  Each buy trade costs a fair amount of charges, so there isn't any reason to spread my SRS money over a large number of stocks.  Secondly, my CDP portfolio is stacked towards healthy companies that can grow their business over time.  There is volatility as the companies go through cyclical upswings and downswings in their respective industry.  For my SRS portfolio, I should be looking for stability and yield maximization, i.e. investing in securities that provide regular distributions and reinvesting the payout, so that my SRS money can compound at a faster clip.  Lastly, prior to 2015, we have to liquidate all our SRS investments into cash for withdrawal after the statutory retirement age.  But now, we can apply to our SRS operator to transfer the investments out of our SRS account into our CDP account, without having to liquidate them (see official answer [here]).  Having just one or two counters in my SRS portfolio will facilitate this transfer.  Do note that any transfer is still subjected to income tax (based on the transferred investment value), though there is a 50% tax concession.

All this rebalancing is going to cost me quite a sum in transaction fees.  I will adjust my SRS holdings gradually over the course of the year.  I shall review the transformation progress in December!

Earnings reporting season is upon us.  Here are the confirmed result release dates for companies in my portfolio:

01 Feb 2024 - SGX
07 Feb 2024 - DBS
22 Feb 2024 - UOB
28 Feb 2024 - OCBC
29 Feb 2024 - ST Engineering

March issuance of the Singapore Savings Bond (SSB) may see a slight uptick in average yield to 2.88% (estimated).  But it is still far below my requirement, so I will not subscribe for the SSB.

My wife and I have started going out together every Friday night, leaving our children at home.  On weekdays, we are busy with work and household chores; on weekends, we are busy with our kids' enrichment classes.  We hardly have time for each other.  Committing to Friday date nights is a way to strengthen our relationship, and to have some quiet time to ourselves.  We're enjoying it!

As you may have noticed, I'm blogging more frequently now.  Hope to put out more articles sharing my experience and insights, so that readers can get an alternate perspective.

The Lunar New Year is just around the corner.  Many Chinese families are spring cleaning and throwing away old junk.  Shopping malls are packed with people buying new stuff, and stocking up food for the reunion dinner.  The bak kwa (barbecued meat slices) and pineapple tart sellers have their best sales around this time of the year.  Many shops have begun selling CNY goodies too.  I can see long queues outside bank branches for the exchange of new dollar notes.  The boisterous crowds simply add to the festive atmosphere.

Signing off for now.  For my Chinese friends, here's wishing you and your family a blissful & prosperous Year of the Dragon!  Gong Xi Fa Cai!




Enjoyed this post? Never miss out new posts by subscribing here.

Saturday, January 20, 2024

When investing, it is okay to...

One morning while I was riding on the MRT train, I caught sight of a lady wearing a green tee-shirt with the following words printed on the back:

"It is okay to pause and relax. The most productive thing you can do is to rest and rejuvenate yourself."

Whoever coined the phrase must be worldly-wise, though I suspect it is the nifty advertising slogan for some product brand.

Nonetheless, it triggered a wave of self-reflection within me.  With the benefit of hindsight and maturity, what are the things I will do now, which I was hesitant about before?

Somehow, the stream of thoughts landed on the topic of investment.  I recalled my experience as an investor over the past two decades.  If I could travel back in time, I would like to teach my younger, rookie self about three things that are okay to do when it comes to investing.

These are the three lessons:


1. It is okay NOT to know everything about a company.

It is important to understand the financial health of a company before buying its stock.  However, there ought to be a limit as to how much research one needs to do before arriving at an investment decision.  If one insists on learning everything about a company first, information overload is bound to occur, which can cause analysis paralysis.  Moreover, if you dig deep enough, confirmation bias will always lead you to find reasons to buy - or not buy - a stock.

Legendary investor Warren Buffett has advised us to only evaluate companies that are within our "circle of competence".  Sadly, I am guilty of committing this transgression.  I have invested in companies where I do not have complete knowledge and are beyond my expertise.

One example is Nanofilm Technologies International (Nanofilm).  Nanofilm specializes in coating technologies.  To be precise, they do Physical Vapour Deposition (PVD) and Filtered Cathodic Vacuum Arc (FCVA) coating.  Nanofilm is also involved in nanofabrication as well as hydrogen energy solutions.  Nanofilm is founded by ex-NTU professor Shi Xu, who is still the Executive Chairman of the company today.  Even though I have an Engineering background, I have absolutely no idea how PVD and FCVA technologies work, what other competitor systems are out there, or how big the market size is.  From this aspect alone, I should have kept a wide berth from this stock.

However, I have reviewed Nanofilm's financial results.  The company has been able to generate a ROE above 10% over the past few years.  Nanofilm has also maintained average gross margin above 40%.  It is also in a net cash position.  Hence, this is a stock that passes my screening criteria.

Granted, due to the slowdown in China's economy, Nanofilm has faced headwinds in its most recent financial year, which diminished its profitability.  Thus, the stock has been brutually sold down by investors.

1-year price chart of Nanofilm Technologies International.

That said, nothing so far has caused me concern to change my investment decision.  I believe the company is still in good shape and will be able to make it through the downswing before improving its earnings again.

So here is Lesson #1: I may not know everything about Nanofilm, but what I do know is good enough for me to decide on owning a stake in the company.


2. It is okay to cut loss and move on.

Historical data has shown that only a small group of super investors are able to achieve market-beating returns consistently year after year.  For the rest of us, we are better off investing our money in low-cost ETFs and holding them till retirement.

So why do I still engage in active stock picking?

The main reason is because I enjoy the process of analysing a business.  I like to find companies that are able to profit their shareholders handsomely over time.

Needless to say, I do not have a perfect track record of picking multi-baggers.  There have been times when the original investment decision looks smart, but as circumstances change, the company is no longer attractive.

One example is SATS Limited (SATS).  This company is no stranger to many Singaporeans.  SATS provides aviation catering as well as gateway services at several international airports and Marina Bay Cruise Centre.  SATS also deals in commercial catering and air cargo handling.  If you have eaten a meal onboard Singapore Airlines, you would have eaten food prepared by SATS ground staff.

When I first invested in SATS, the company had very healthy margins and a low debt burden.  Unfortunately, the COVID-19 pandemic grounded air travel to a halt and SATS suffered a massive loss during the period.  The company had to retrench staff and withhold its dividend so as to conserve cash.  These are understandable measures for the firm to survive through the crisis.

But when SATS acquired Worldwide Flight Services at a hefty price tag of 1.3 billion euros (S$1.9 billion), the company had to issue new shares and take on significant debt, which changed the financial health of the company.  Despite the recovery in international air travel, SATS has yet to turn in a profit.  With a heavier debt burden and inflationary costs eating into its margins, there is no guarantee how long SATS will take to return to the same level of profitability in its golden years.

The market is aware of SATS' predicament.  The stock has been stuck in the $2+ range for some time now and has not been able to recover to the height of the $4+ range in the past.

5-year price chart of SATS Limited.

When a company's situation has changed significantly, it is imperative to review whether your original investment rationale still holds.  If it does not, then the stock should be sold.

In December last year, I sold my position in SATS at a loss.  It was a painful decision, but I figured it is way better than having to pray continuously for the day when SATS can achieve positive shareholder return again.

So here is Lesson #2: When things have changed for the worse, don't dither and hope for a miracle.  It is okay to cut loss on your investment and move on.


3. It is okay to be a lonely investor.

Singaporean investors are a dividend loving bunch, and S-Reits appeal to many people for their high yield.  It is common to find fellow retail investors holding the same S-Reits in their portfolios.

On the other hand, our local small caps are not well covered by broker analysts and liquidity is low most of the time.  If one has found a highly investible candidate, chances are nobody in your social circle knows about it, let alone holds it in their portfolio.  Hence, there is no comfort of the masses to speak of.

Either one ends up as an astute investor when the price soars after market recognition of its hidden value, or one ends up as a fool for buying a dud that remains rangebound in price.

Given the above outcome, will you still consider investing in small caps?  Will you still want to be a lonely investor?

For me, I have decided long ago to go on ahead and invest in the small caps anyway.  This is why you will see a few lesser known entities in my portfolio.  Even if the stock fails to garner public attention, as long as the company remains profitable and financially strong, and the management act with shareholders' interest in mind, I will gladly park my money in the stock.

And this is Lesson #3: Trust in your own analysis and buy the small cap stock.  It is okay to be a lonely investor.


I hope you have found some food for thought from the three lessons above.  I know my younger self would.

Thank you for reading.



Enjoyed this post? Never miss out new posts by subscribing here.

Thursday, August 31, 2023

Portfolio Summary for August 2023

As of 31 August 2023

CDP

Security # shares Price S$ %
DBS 400 33.30 3.71
UOB 400 28.44 3.17
OCBC Bank 700 12.55 2.45
SGX 2,700 9.63 7.24
ST Engineering 6,900 3.81 7.32
CapitaLand Investment 7,400 3.24 6.68
SATS 8,200 2.59 5.92
Powermatic Data 8,500 2.80 6.63
TheHourGlass 5,000 1.96 2.73
Micro-Mechanics 14,200 1.89 7.48
VICOM 17,800 1.55 7.69
Sheng Siong 19,100 1.52 8.09
Nanofilm 21,600 1.06 6.38
Genting Singapore 11,700 0.875 2.85
Credit Bureau Asia 14,300 0.925 3.69
HRnetGroup 21,900 0.745 4.55
TalkMed Group 14,500 0.40 1.62
China Sunsine 41,800 0.40 4.66
HC Surgical 35,500 0.36 3.56
Kimly 27,000 0.32 2.41
Silverlake Axis 15,000 0.285 1.19
Portfolio Market Value = $358,937
YTD Dividends Received = $10,229
YTD SBL Fees Received = $801

Trades
- Bought 6,200 shares of Nanofilm.
- Bought 3,800 shares of VICOM.
- Bought 6,100 shares of Sheng Siong.

SRS

Security # shares Price S$ %
DBS 100 33.30 2.52
UOB 200 28.44 4.30
OCBC Bank 900 12.55 8.54
SGX 1,300 9.63 9.46
ST Engineering 3,000 3.81 8.64
CapitaLand Investment 2,600 3.24 6.37
SATS 3,800 2.59 7.44
Powermatic Data 3,400 2.80 7.19
Micro-Mechanics 5,400 1.89 7.71
VICOM 5,500 1.55 6.44
Sheng Siong 8,700 1.52 9.99
Nanofilm 5,500 1.06 4.41
Credit Bureau Asia 5,700 0.925 3.98
TalkMed Group 5,800 0.40 1.75
China Sunsine 10,800 0.40 3.26
HC Surgical 19,500 0.36 5.30
Kimly 5,800 0.32 1.40
Silverlake Axis 6,000 0.285 1.29
Portfolio Market Value = $132,332

Trades
None

Singapore Savings Bonds

Security Amount ($) Avg Yld %
GX18070N 12,500 2.63
GX22120S 14,000 3.47
GX23010Z 15,000 3.26
Portfolio Market Value = $41,500

Commentary:
I enjoyed August. My family celebrated three birthdays; term tests are over for my kiddos and I took a handful of leave days to get away from work. I was able to take things down a notch and recharge my spirit.

Investments-wise, nothing major happened in my portfolios. As the price of Nanofilm sunk to an all-time low, I took another bite. I find this company to be a good indicator of China's manufacturing industry right now, which isn't performing well. Nonetheless, I'm confident the company fundamentals are still intact. Growth will resume once China is able to revitalize its production-led economy.

I also picked up Vicom and Sheng Siong as their stock prices retreated. I'm eyeing the local banks too. Their prices have steadily declined, despite having achieved stellar Q3 results. Once they hit my entry point, I will accumulate. The banks are the strongest candidates to raise their dividends.

Speaking of banks, I came across a good article in the Business Times titled "Bank customers lose out as industry holds on to rate-hike gains" [link]. Banks do not always pass on the interest rate hikes to savers. That is why there is NIM expansion. IMO, it is better to be both a saver and a bank stockholder.

The year-to-date dividend income from my CDP portfolio has crossed $10k. While it isn't a lot of money (when you average it out per month), I had saved my hard-earned money and invested instead of splurging on stuff. It is the fruit of my frugality. I sincerely hope my dividend income stream will continue to grow over the years.

As mentioned previously, I'm in the midst of adjusting my investment focus. I want to ditch the lower ROE stocks in favour of the few stronger companies. But at present, I don't see an urgent need to sell off those holdings when prices are going nowhere. Moreover, I have sufficient dry powder (cash) to add on positions when a buying opportunity appears. So I'm adopting a wait-and-see attitude. Akan datang.

We are already three quarters into 2023. After spending eight years in my current job, I've decided to apply for a Sales role in another department. The skill set required is way out of my comfort zone. Yet, there is the thrill of embarking on a new challenge and stretching my capabilities further. It has been a long time since I last attended an interview. I sought advice from my former colleagues who are now in Sales. I'm glad to see them enjoying the job and thriving. I hope to follow in their footsteps. I've pored over YouTube videos on Sales interview tips and tricks, so that I can be prepared. I have told myself - Even if I do not get the job, at least I've done my best and benefited from the learning experience. No regrets.

Wish me luck!




Enjoyed this post? Never miss out new posts by subscribing here.

Wednesday, November 30, 2022

Portfolio Summary for November 2022

As of 30 November 2022

CDP

Security# sharesPrice S$%
DBS30035.192.85
UOB30031.202.53
OCBC Bank70012.442.35
SGX2,7009.056.60
iFast5,7005.308.16
SATS3,9002.672.81
ST Engineering6,9003.436.39
CapitaLand Investment7,4003.677.33
Micro-Mechanics8,4002.766.26
Powermatic Data8,5002.656.08
Nanofilm15,4001.335.53
TheHourGlass5,0002.142.89
Vicom11,8001.926.12
Sheng Siong13,0001.655.79
ComfortDelGro11,2001.233.72
Credit Bureau Asia14,3000.953.67
Genting Singapore11,7000.882.78
HRnetGroup21,9000.7954.70
HC Surgical35,5000.343.26
China Sunsine41,8000.4054.57
TalkMed Group14,5000.381.49
Kimly27,0000.3552.59
Silverlake Axis15,0000.3751.52
Portfolio Market Value = $370,292

Trades
- Bought 2,200 shares of Nanofilm Technologies.

SRS

Security# sharesPrice S$%
OCBC Bank90012.448.03
SGX1,3009.058.44
iFast2,1005.307.98
SATS2,2002.674.21
ST Engineering3,0003.437.38
CapitaLand Investment2,6003.676.84
Micro-Mechanics3,1002.766.13
Powermatic Data3,4002.656.46
Nanofilm5,5001.335.24
Vicom4,7001.926.47
Sheng Siong8,7001.6510.29
ComfortDelGro6,9001.236.08
Credit Bureau Asia5,7000.953.88
HC Surgical19,5000.344.75
China Sunsine10,8000.4053.14
TalkMed Group5,8000.381.58
Kimly5,8000.3551.48
Silverlake Axis6,0000.3751.61
Portfolio Market Value = $139,476

Trades
- Bought 1,400 shares of Nanofilm Technologies.

Singapore Savings Bonds

SecurityAmount ($)
GX18070N12,500
GX22120S14,000
Portfolio Market Value = $26,500

Commentary
The equity markets had no lack of action in the month of November.  Whenever there was any sign that the U.S. Fed may hike interest rate less than expected, the markets shot up.  Whenever there was any sign that China may go into lockdown mode (again), the markets tanked.

It has been a long time ago that we have seen interest rates in the region of 3 to 4 percent.  A recent poll of experts put the terminal Fed Funds Rate at around 4.75 to 5 percent [news].  If that is the case, the lending rate on mortgages is likely to peak between 5 and 6 percent.  The MAS warned that with rising interest rates and growing cost pressures due to elevated inflation, some households are likely to face increasing financial stress and may encounter difficulties in servicing their mortgages [news].

Price of Nanofilm Technologies plunged to an all-time low, as investors grew despondent about China's Zero-COVID policy, despite the fact that Nanofilm reported a 10% YoY revenue growth [here] for 9M2022.  I loaded on the shares, as I believe the company's long-term prospect is still good.  Again, I emphasize Nanofilm is one of my three strategic bets, and is unlikey to generate positive cashflows in the near term.

I had some major expenses this month which drained my savings till it nearly hit the minimum account limit.  I was tempted to transfer money out of my portfolio cash account, but that would totally destroy my 'pay oneself first' habit.  One transgression will soon lead to another.  Thankfully, the dividends were credited in the nick of time.

I received dividends from SGX, HC Surgical Specialists, Silverlake Axis, Micro-Mechanics, iFast, DBS and The Hour Glass, which literally saved me.  The amount totaled $1,701.10.  While it was not much, it is after all, the fruit of my investment strategy, and I cherished every cent.

I am looking forward to the day when my portfolio can provide sufficient passive income to cover my expenses so that I can call it a day from my job.  That said, it is not prudent to rely solely on dividends alone.  As the recent COVID-19 pandemic demonstrated, companies can cut dividends in a jiffy to conserve cash.  One will need to have multiple streams of income to tide over any crisis.

At an average yield above 3 percent, the Singapore Savings Bond (SSB) is looking increasingly attractive compared to equities on a risk-reward basis.  I will begin to subscribe for them again.  The demand is red-hot, according to what I have read [news].

Financial matters aside, I just came back from a cruise trip onboard Royal Caribbean's Spectrum of the Seas.  It was a wonderful break for me, even though the ship was packed to the brim with people.  I heard from the service staff that the ship is fully booked (5,000-plus guests) till the end of December.  Luckily, I chose the Grand Suite, so we had a separate dining area which is what I enjoyed the most.  No need to chope seats during mealtimes.  However, we still had to queue one and a half hours to play the Bumper Cars.  We also had to queue early to get good seats for the shows.

At the Royal Theatre, waiting for the show to start.

Nonetheless, it was a better experience compared to our previous three cruises, as my sons are older now and they can navigate their own way around the ship, choosing their activities while my wife and I simply laze around.  I also tried Ripcord by iFly, my first air tunnel skydiving experience.  It was truly memorable.  (I wish I can try skydiving for real, but my wife will surely object!)

For those who have never been on a cruise before, I strongly recommend to try it, but during an off-peak season if you don't like crowds.

We have finally reached the last month of the year.  2022 has been marred by the Russian-Ukraine war, as well as runaway inflation.  While the COVID-19 pandemic is still ongoing, it is less of a concern now, judging by the large number of Singaporeans who choose not to wear a mask in public unless mandated.  I sincerely hope things will get better next year.  My grand wish is for the war to end, the pandemic to cease, inflation to be contained, and the recession to be averted.

Here's wishing you and your family Happy Holidays!




Enjoyed this post? Never miss out new posts by subscribing here.

Monday, October 31, 2022

Portfolio Summary for October 2022

As of 31 October 2022

CDP

Security# sharesPrice S$%
DBS30034.202.90
UOB30027.762.36
OCBC Bank70012.132.40
SGX2,7008.426.44
iFast5,7004.056.54
SATS3,9002.733.01
ST Engineering6,9003.306.45
CapitaLand Investment7,4003.016.31
Micro-Mechanics8,4002.756.54
Powermatic Data8,5002.606.26
Nanofilm13,2001.746.50
TheHourGlass5,0001.952.76
Vicom11,8001.886.28
Sheng Siong13,0001.565.74
ComfortDelGro11,2001.274.03
Credit Bureau Asia14,3000.963.89
Genting Singapore11,7000.8052.67
HRnetGroup21,9000.734.53
HC Surgical35,5000.383.82
China Sunsine41,8000.424.97
TalkMed Group14,5000.401.64
Kimly27,0000.342.60
Silverlake Axis15,0000.3251.38
Portfolio Market Value = $353,230

Trade Actions
- Bought 1,500 shares of SGX.
- Bought 3,900 shares of CapitaLand Investment.
- Bought 2,800 shares of Nanofilm.

SRS

Security# sharesPrice S$%
OCBC Bank90012.138.18
SGX1,3008.428.20
iFast2,1004.056.37
SATS2,2002.734.50
ST Engineering3,0003.307.42
CapitaLand Investment2,6003.015.87
Micro-Mechanics3,1002.756.39
Powermatic Data3,4002.606.63
Nanofilm4,1001.745.35
Vicom4,7001.886.62
Sheng Siong8,7001.5610.17
ComfortDelGro6,9001.276.57
Credit Bureau Asia5,7000.964.10
HC Surgical19,5000.385.55
China Sunsine10,8000.423.40
TalkMed Group5,8000.401.74
Kimly5,8000.341.48
Silverlake Axis6,0000.3251.46
Portfolio Market Value = $133,430

Trade Actions
- None

Commentary:
Another month flew past, but not without my stock alerts triggering almost daily as the general stock market sank lower by the day.  I took opportunity of the sour mood and loaded up on shares of SGX, CapitaLand Investment and Nanofilm Technologies.  I was tempted to add other stocks too, but I refrained.  (Have to keep my portfolio balanced.)

UOB reported a sterling set of 3QFY2022 result [here].  Net profit rose to S$1.4 billion, up 34% YoY.  Net interest margin expanded 40 basis points.  The positive result had been widely expected by investors.  Nonetheless, UOB's stock price skyrocketed 6.7% in the two days post-earning release.  Local banking stocks DBS and OCBC also gained from the sentiment.  DBS is set to report its results on 3 Nov; OCBC is set to report on 4 Nov.

My cash stash has reduced to approx. 16%.  I need to be selective on which stocks to add hereon.  Banks are currently bathed in this favourable light amid the rising interest rate environment, so it will be hard to pile on them at an attractive price.  I am also keeping an eye on The Hour Glass.  I sold the stock back in March this year.  Hope to build my position again as the market retreats due to recessionary fears.

Family-wise, my wife and I are looking forward to our Royal Caribbean cruise trip in November.  It will be a welcome break after a hectic year at work.

Until next time!




Enjoyed this post? Never miss out new posts by subscribing here.

Sunday, July 31, 2022

Portfolio Summary for July 2022

As of 31 July 2022

CDP

Security# sharesPrice S$%
DBS30031.472.84
UOB30027.552.49
OCBC Bank70011.672.46
SGX1,2009.903.57
iFast5,7004.217.22
SATS3,9003.974.66
ST Engineering4,1004.024.96
Micro-Mechanics8,4002.987.53
Powermatic Data8,5002.757.03
Nanofilm10,4002.016.29
TheHourGlass5,0002.223.34
Vicom11,8002.067.31
Sheng Siong13,0001.606.26
ComfortDelGro11,2001.424.79
Credit Bureau Asia14,3000.994.26
Genting Singapore11,7000.8052.83
HRnetGroup21,9000.785.14
HC Surgical35,5000.4755.07
China Sunsine41,8000.4355.47
TalkMed Group14,5000.391.70
Kimly27,0000.3652.97
Silverlake Axis15,0000.401.81
Portfolio Market Value = $332,353

Trade Actions
- Bought 10,400 shares of Nanofilm Technologies.
- Bought 14,300 shares of Credit Bureau Asia.

SRS

Security# sharesPrice S$%
OCBC Bank90011.677.64
SGX1,3009.909.36
iFast2,1004.216.43
SATS2,2003.976.35
ST Engineering3,0004.028.77
Micro-Mechanics3,1002.986.72
Powermatic Data3,4002.756.80
Nanofilm4,1002.015.99
Vicom4,7002.067.04
Sheng Siong8,7001.6010.12
ComfortDelGro6,9001.427.13
Credit Bureau Asia5,7000.994.10
HC Surgical19,5000.4756.74
China Sunsine10,8000.4353.42
TalkMed Group5,8000.391.65
Silverlake Axis6,0000.401.75
Portfolio Market Value = $137,503

Trade Actions
- Bought 4,100 shares of Nanofilm Technologies.
- Bought 5,700 shares of Credit Bureau Asia.

Commentary:
July has been a hectic month at work, so I hadn't paid much attention to the market. July also heralded the start of Q2 earnings reporting season, with UOB reporting 11% YoY increase in Q2 net income yesterday, but its share price dropped due to downbeat sentiment.

The U.S. Fed hiked interest rate by 75 basis points this month, which was largely within investors' expectations. In Singapore, the MAS reported Core Inflation rose to 4.4% YoY in June from 3.6% in May [report]. It is going to be a while more before we will see any tapering.

I added another watchlist target to my portfolios - Nanofilm Technologies. This company, together with iFast and Credit Bureau Asia are my strategic bets. Even when these companies hardly pay a decent dividend now, I like their ROE, profit margins and growth potential in their respective areas. I must confess though - I don't fully understand Nanofilm's proprietary technology, and I cannot ascertain whether a newer discovery may render the technology obsolete. This contravenes Buffett's advice of staying within one's circle of competence. Caveat emptor. 

Heading into August, my cash hoard stands around 23% of total portfolio value. I have set market alerts around preferred price levels for the stocks on my watchlist, so that I do not miss out while burying myself in tons of work.

Take care!




Enjoyed this post? Never miss out new posts by subscribing here.